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T follicular  helper  (Tfh)  cells,  a true  B cell helper,  have  a  critical  role  in  enhancing  humoral  immune
responses.  However,  the  initial  differentiation  of  Tfh cells  by  dendritic  cells  (DCs),  the  most  potent  anti-
gen  presenting  cells,  has  not  been  clearly  understood,  particularly  in the  knowledge  of  the  two  major
conventional  dendritic  cell  subsets,  CD8+ DCs  or CD8− DCs. Here  we  demonstrated  that  the  localiza-
tion  of CD8− DCs  in  the marginal  zone  (MZ)  bridging  channels  is closely  associated  with  the  induction  of
CXCR5+CCR7low Tfh  cells.  We  also showed  that the  major  source  of  IL-6  for inducing  Tfh  cells  is  provided
from  the activated  CD4+ T cells  induced  by  CD8− DCs,  and  IL-6  directly  secreted  from  the  DC  subsets
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seems  minor.  CD8 DCs were  superior  in  inducing  functional  Tfh  cells  over  other  antigen  presenting
cells  including  B cells.  We  here  observed  the  unknown  intrinsic  features  of  the  DC  subsets,  suggesting  the
potential  of utilizing  the  CD8− DC  subset  as therapeutic  vaccine  for the  regulation  of  humoral  immune
responses.
© 2016  The  Authors.  Published  by Elsevier  B.V.  on behalf  of  European  Federation  of Immunological
Societies. This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/. Introduction
T follicular helper (Tfh) cells are identiﬁed as the true B cell
elper and have been noted for their capability of modulating T
ell dependent humoral immune responses [1,2]. Since the role
f CXCR5 in Tfh cells was reported, leading its CXCL13 dependent
igration into the germinal center (GC) [3,4], several discrete fea-
ures of Tfh cells such as high expressions of ICOS and PD1 or low
xpression of CCR7, transcription factor Bcl6, and major cytokine
L-21 were identiﬁed [5]. In addition, the clinical importance of
fh cells involved in humoral immunity related diseases such as
utoimmunity and humoral immunodeﬁciency was reported [6],
nd thus the understanding the initiation of the Tfh cell differenti-
tion is urgent and crucial. Although many researches have actively
dentiﬁed speciﬁc features of Tfh cells, how naïve CD4+ T cells dif-
erentiate into Tfh cells is not clearly understood.
∗ Corresponding author at: Soonchunhyang Institute of Med−bio Sciences (SIMS),
honan−Si  31538, Republic of Korea.
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165-2478/© 2016 The Authors. Published by Elsevier B.V. on behalf of European Federatio
icense  (http://creativecommons.org/licenses/by-nc-nd/4.0/).licenses/by-nc-nd/4.0/).
Dendritic cell (DC), the most potent antigen presenting cell
(APC), is the key modulator in inducing several CD4+ effector T
cell subsets [7]. Two  major conventional DC subsets in the sec-
ondary lymphoid organs are deﬁned by the expression of CD8,
either CD11c+CD8+ DCs expressing the endocytic receptor DEC-
205 or CD11c+CD8− DCs expressing the endocytic receptor DCIR2
[8,9]. We  recently reported that the conventional CD8− DC subset
is superior over CD8+ DCs in inducing functional Tfh cells both
in vitro and in vivo, generating efﬁcient antigen speciﬁc humoral
immune responses [10]. CD8− DCs were very effective in enhanc-
ing the number of antigen speciﬁc Tfh cells, the formation of
germinal centers, and the quality and quantity of antibody titers
against human pathogenic antigens such as Yersinia pestis LcrV,
HIV Gag and Hepatitis B surface antigen [10]. We also reported the
signiﬁcance of ICOSL and OX40L expressed on CD8− DCs via the
highly enhanced non-canonical NF-B signaling pathway in induc-
ing functional Tfh cells [10]. However, several important features
such as the proximal location of the two DC subsets to antigen spe-
ciﬁc CD4+ T cells in vivo, cytokines secreted from the DC subsets
and the potential involvement of other APCs, majorly B cells, in the
induction of Tfh cells have not been addressed. Thus, the aim of the
present study was to examine the undescribed intrinsic features of
n of Immunological Societies. This is an open access article under the CC BY-NC-ND
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Fig. 1. CD4+ T cells primed by CD8− DCs localized in the MZ  bridging channels. OVA speciﬁc DO11.10+CD4+ T cells were adoptively transferred to naive BALB/c mice at day




















gn  the presence of poly (I:C) at day 0. At each indicated time point after the immun
nd  detected by ﬂuorescence confocal microscopy. IgD, green; DO11.10, red; DEC2
ore  independent experiments (n > 10 per group). (For interpretation of the referen
he two DC subsets in the initiation of Tfh cell differentiation by
tilizing DC subset targeting strategy and puriﬁed DC subsets.
. Materials and methods
.1. Mice
BALB/c (H-2d) and C57BL/6 (H-2b) mice were purchased from
aconic, and OT-II and DO11.10 Thy 1.1 mice were purchased from
he Jackson Laboratory. All mice were maintained under speciﬁc
athogen-free conditions and used at 6–8 weeks approved by Ulsan
ational Institute of Science and Technology Institutional Animal
are and Use Committee (approval number: UNISTIACUC-12-006-
).
.2. Dendritic cell preparation
Total number of splenic dendritic cells was increased by
ms-like tyrosine 3 ligand (Flt3L) as previously described [9].
n brief, 5 × 106 cells of Flt3L-melanoma cells were subcuta-
eously (s.c.) injected to naïve C57BL/6 mice. After 10–14 days,
he expanded splenic CD11c+ DCs were enriched with positive
agnetic-activated cell sorting (MACS; Miltenyi Biotec, GmbH, Ber-
isch Gladbach, Germany) and were further sorted into the two  DC, immunohistochemical staining of spleen sections from each group was prepared
r CD8+ DCs) or DCIR2 (for CD8− DCs), blue. Data are representative of three or
 color in this ﬁgure legend, the reader is referred to the web version of this article.)
subsets, CD3−B220−CD11c+CD8+ or CD3−B220−CD11c+CD8−
DCs by MoFlo XDP (Beckman Coulter, Brea, CA, USA). To analyze
cytokines or surface marker expressions in/on the two DC subsets,
the puriﬁed each DC subset was stimulated either with 25 g/ml
poly (I:C) or 100 ng/ml LPS for 12 or 24 h in vitro.
2.3. CD4+ T cell preparation
OVA-speciﬁc transgenic CD4+ T cells from the lymph nodes and
the spleen of OT-II or DO11.10 Thy1.1 mice were negatively iso-
lated using hybridoma supernatant cocktail of rat-anti mouse −CD8
(2.43), −MHC  class II (T1B120), −M (F4/80), −B220 (RA3-6B2),
and −NK cell (NK1.1) antibodies followed by depletion with dyn-
abeads sheep anti-rat IgG (Invitrogen, Carlsbad, CA, USA).
2.4. CD4+ T cell priming by the DC subsets in vitro
Naive OVA-speciﬁc CD4+ T (3 × 105) cells puriﬁed from OT-II
mice were co-cultured either with sorted CD8+ or CD8− DCs
(each 0.3 × 105 DCs, 1:10 ratio of DC to T cells) per well in the round
bottom 96 well plate for 3 days in the presence of 25 g/ml poly
(I:C) or 100 ng/ml LPS with 2 M OVA peptide (a.a. 323–339) (Gen-
script, Piscataway, NJ, USA). Then, cytokines in supernatants were
detected by ELISA.
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Fig. 2. Induction of CXCR5+CCR7low Tfh cells by CD8− DCs in vivo. (A–D) OVA speciﬁc DO11.10+Thy1.1+CD4+ T cells were adoptively transferred to naive Thy1.2+ BALB/c













ponjugated mAbs in the presence of poly (I:C) at day 0. At each indicated time poi
ells  gated from the Thy1.1+CD4+ T cells were analyzed. (A and C) Representative 
epresent mean ± s.e.m. of three independent experiments described in (A) or (C), r
.5. Induction of CD4+ T cells by DC subset targeting in vivo
Isolated CD4+ T cells from DO11.10 Thy 1.1 mice were adoptively
ransferred (3 × 106 cells per mouse) into naïve Thy 1.2+ BALB/c
ice intravenously (i.v.) at day −1. At day 0, PBS, 500 g solu-
le OVA protein (endotoxin-free; Seikagaku Corp, Tokyo, Japan),
r 5 g of each distinct DC subset targeting monoclonal antibod-
es (anti-DEC-205 or anti-DCIR2 mAbs) genetically conjugated with
VA protein in the presence of 50 g poly (I:C) were injected via
he footpads of the mice. At the indicated time points after the
mmunization, single cells from the lymph nodes or the spleen were
repared and analyzed for the expression of various molecules byr the immunization, lymph node (LN) or spleen (SP) cells were prepared and Tfh
ytometry plots of CD44+CXCR5+ (A) or CD44+CCR7low (C) Tfh cells. (B and D) Data
tively. * P < 0.05, ** P < 0.01, *** P < 0.001. (A–D, n = 3 per group).
ﬂow cytometry. In some experiments, 5 g of each distinct DC sub-
set targeting mAbs conjugated with OVA protein + 50 g soluble
OVA protein with 50 g LPS were injected via the footpads of the
mice at day 0.
2.6. Production of DC subset-speciﬁc targeting antibodies
conjugated with OVA proteinDC subset-speciﬁc targeting antibodies conjugated with OVA
protein were used as previously described [11,12]. All proteins used
were free of endotoxin (<0.125 endotoxin units/mg) in a Limulus
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Fig. 3. IL-6 cytokine secreted from the DC subsets or the CD4+ T cells induced by the DC subsets and maturation markers on the DC subsets. (A and B) ELISA analysis of the
cytokines, IL-1, IL-6, TNF-, secreted from each puriﬁed DC subset stimulated either with poly (I:C) (A) or LPS (B) for 12 or 24 h. * P < 0.05. Data represent mean ± s.e.m. of
three  independent experiments (A and B). (C) OT-II OVA speciﬁc V2+CD4+ T cells were co-cultured with each DC subset in the presence of OVA peptide (323–339) either
with  poly (I:C) or LPS. After 3 days of the co-culture, the level of IL-6 cytokine in the supernatant was  measured by ELISA. ** P < 0.01, *** P < 0.001. (D) Maturation markers
expressed on the two DC subsets. Each DC subset was stimulated either with poly (I:C) or LPS for 0 (immature) or 24 h (mature). Representative histograms of CD80, CD86
or  MHCII expressed on the two DC subsets. Data are representative of three independent experiments.
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Fig. 4. CD8− DCs specialize in inducing functional Tfh cells in vivo. OVA speciﬁc DO11.10+CD4+ T cells were adoptively transferred to naive BALB/c mice at day −1, and
were  immunized s.c. either with DEC:OVA (CD8+ DC targeting) or DCIR2:OVA (CD8− DC targeting) conjugated mAbs in the presence of soluble OVA protein + LPS. 5
days  after the immunization, lymph node cells (A and B) or spleen cells (C–F) were prepared and Tfh cells gated from the DO11.10+CD4+CD44+ T cells were analyzed. (A and
C)  Representative ﬂow cytometry plots of CXCR5+PD1+, CXCR5+Bcl6+, or CXCR5+IL-21+ Tfh cells. (B and D) Data represent mean ± s.e.m. of three independent experiments
described in (A) or (C), respectively. (E) Representative ﬂow cytometry plots of GL7+FAS+ germinal center (GC) B cells gated from CD19+IgD− splenocytes. (F) Data represent
mean  ± s.e.m. of three independent experiments described in (E). (G) ELISA analyses of OVA-speciﬁc serum IgM or IgG antibodies. Data represent mean ± s.e.m. of three
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mebocyte Lysate assay, QCL-1000 (Bio Whittaker, Chesterbrook,
A, USA).
.7. ELISA for serum antibodies and cytokines
High binding ELISA plates (BD Bioscience, San Jose, CA, USA)
ere coated with 10 g/ml OVA protein overnight at 4 ◦C. Plates
ere washed 3 times with PBST (PBS with 0.1% of Tween 20)
nd blocked with PBST-BSA 5% for 1 h at 37 ◦C. Serial dilutions of
ouse serum were added and incubated for 1 h at 37 ◦C. Secondary
oat anti-mouse IgM or IgG speciﬁc antibodies conjugated with
orseradish peroxidase were added and incubated for 1 h at 37 ◦C,
nd then developed with o-phenylenediamine (Sigma–Aldrich, St.
ouis, MO,  USA) tablets at room temperature for 15 min. Data are
resented as log antibody titers, with the highest dilution showing
D450 >0.1. To detect cytokines in supernatants, we used CBA ﬂex
ets (BD Bioscience) and the concentrations of various cytokines
ere measured by ﬂow cytometry.
.8. Immunohistochemistry
Brieﬂy, tissue sections (10 m)  of the spleen were prepared by
sing Cryotome (Thermo Fisher scientiﬁc, Waltham, MA,  USA) and
hen ﬁxed with aceton on a slide. For localization images of DCs and
D4+ T cells, samples were stained with BV-421 anti-mouse IgD
BioLegend, San Diego, CA, USA), PE anti-mouse DO11.10 (BD Bio-
ciences), and APC anti-mouse DEC205 or DCIR2 (BioLegend). Then,
he stained samples were imaged with FV10i (Olympus, Southend-
n-Sea, UK) confocal microscope.
.9. Flow cytometry
Data were acquired by BD FACS Calibur or BD LSR fortessa and
nalyzed by FlowJo software (TreeStar, Ashland, OR, USA), shown
n the log scale graph (from 101 to 104 or 105). All bar graph
ata values were shown after subtracting their corresponding iso-
ype values. Median Fluorescence Intensity was abbreviated as MFI.
sed antibodies in ﬂow cytometry as follows: CD11c (HL3), CD8
53-6.7), CD3 (145-2C11), B220 (RA3-6B2), V2 (B20.1), Thy1.1
OX-7), DO11.10 (KJ1-26), CD4 (RM4-5), CD44 (IM7), CXCR5 (2G8),
cl6 (K112-91), CCR7 (4B12), CD19 (1D3), IgD (11-26C.2A), FAS
Jo2), GL7 (GL7), CD80 (16-10A1), CD86(GL1), MHCII (M5/114),
at IgG2a,  (R35-95), and Rat IgG2b,  (A95-1) were purchased
rom BD biosciences; PD1 (RMP1-30) and IL-21 (mhalx21) were
urchased from eBioscience, San Diego, CA, USA.
.10. Intracellular staining
Cells were stained with anti-mouse DO11.10, CD4, CD44
nd CXCR5 for 30 min  at room temperature. Following ﬁxation
nd permeabilization with Cytoﬁx/Cytoperm kit (BD Biosciences)
ccording to the manufacturer’s protocol, the cells were stained for
ntracellular Bcl6 or IL-21 along with their isotypes for 25 min  at
◦C. Data were analyzed by ﬂow cytometry.
.11. StatisticsResults are expressed as mean ± s.e.m. We  used PRISM 4.0
rogram (GraphPad Prism, La Jolla, CA, USA) and performed non-
arametric Mann–Whitney U test when appropriate. The P values
0.05 were considered signiﬁcant.tters 172 (2016) 21–28
3. Results
3.1. CD8˛− DC induced CD4+ T cells are localized proximal to
CD8˛− DCs in the marginal zone (MZ) bridging channels
In order to deliver ovalbumin (OVA) antigens to each DC sub-
set speciﬁcally in vivo, we  utilized DC subset targeting monoclonal
antibodies (mAbs) genetically conjugated with OVA protein, DEC-
205:OVA (for targeting CD8+ DCs) or DCIR2:OVA (for targeting
CD8− DCs) mAbs. Then, we  examined the localizations of the two
DC subsets together with OVA antigen speciﬁc DO11.10+CD4+ T
cells primed by each of the DC subsets. As previously reported
[9], we  conﬁrmed the different localizations of the two DC sub-
sets in the spleen; CD8+ DCs predominantly localize in the T cell
enriched region while CD8− DCs localize in the MZ  bridging chan-
nels (Fig. 1). Interestingly, the CD4+ T cells induced by CD8− DCs
tended to localize in the MZ  bridging channels proximal to CD8−
DCs as early as 1 day after the immunization, and 3 and 5 days
after the immunization, the CD4+ T cells predominantly localized
in the MZ  bridging channels. In contrast, the CD4+ T cells induced
by CD8+ DCs remained in the T cell enriched region at all-time
points tested (Fig. 1).
3.2. CD4+ T cells induced by CD8˛− DCs express high levels of
CXCR5 and low levels of CCR7
Based on the fact that pre-Tfh cells up-regulate CXCR5
while down-regulating CCR7 to migrate into the inter-follicular
region/MZ bridging channels [13,14], where the development of Tfh
cell initiates [15], we  examined the expressions of CXCR5 and CCR7
on the antigen speciﬁcally activated CD44+CD4+ T cells induced by
the two DC subsets. We  found high expression of CXCR5 on the CD4+
T cells induced by CD8− DCs compared with that on the CD4+ T
cells induced by CD8+ DCs at 5 and 7 days after the immuniza-
tion, both in the lymph node and the spleen (Fig. 2A and B), and the
percentage of CCR7lowCD4+ T cells induced by CD8− DCs  was sig-
niﬁcantly increased (Fig. 2C and D), suggesting that the pre-Tfh cells
induced by CD8− DCs tended to localize in the MZ bridging chan-
nels via CXCR5–CXCL13 interaction. In contrast, CD8+ DC induced
CXCR5lowCCR7high CD4+ T cells remained in the T cell enriched area
via CCR7-CCL19/21 interaction (Fig. 2A–D).
3.3. Level of IL-6 cytokine secreted from the two DC subsets is
dependent on an adjuvant type
Despite previous reports demonstrating the importance of
interleukin-6 (IL-6) in inducing Tfh cells [16,17], its source,
together with the possibility of its secretion from the DC  subsets,
were not clearly understood. In order to examine and quan-
tify IL-6 and other cytokines secreted from each DC subset, we
isolated the two DC subsets, CD3−B220−CD11c+CD8+ DCs and
CD3−B220−CD11c+CD8− DCs. Each puriﬁed DC subset was stim-
ulated either solely with poly (I:C) or LPS for 12, 24 h in vitro.
Unexpectedly, upon poly (I:C) stimulation, we  found signiﬁcantly
enhanced IL-6 secretion from CD8+ DCs compared with that from
CD8− DCs (Fig. 3A). However, in the presence of LPS, IL-6 secre-
tion amount was  similar between the two  DC subsets 12 h after the
stimulation and its level from CD8− DCs became higher 24 h after
the stimulation (Fig. 3B). Interestingly, the OVA speciﬁc CD4+ T cells
induced by CD8− DCs in the presence of OVA peptide secreted
signiﬁcantly higher level of IL-6 cytokine regardless of the types
of adjuvant (Fig. 3C), suggesting the lesser role of IL-6 secreted
from the two DC subsets in inducing Tfh cells. Pro-inﬂammatory
cytokines such as IL-1 and TNF- were highly secreted from
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). The expression levels of maturation markers CD80, CD86 and
HCII were comparable between the two DC subsets (Fig. 3D).
.4. CD8˛− DCs are superior in inducing functional Tfh cells
One previous study demonstrated that CD8− DCIR2+ DCs
ave a unique capacity to initiate extra-follicular B cell responses
hrough rapid activation of Ag-speciﬁc B cells [18], suggesting the
ossibility that the two DC subsets are differentially able to deliver
ntigens to cognate B cells in inducing antigen speciﬁc humoral
mmune responses. In order to examine the effect of different anti-
en accessibility of APCs including B cells on the induction of Tfh
ells upon distinct DC subset targeting, we designed an experi-
ent to equivalently provide antigens to all APCs in both CD8+
nd CD8− DC targeted groups. When we immunized mice with
 g of each DC subset speciﬁc targeting mAbs conjugated with
VA protein (each immunization contains ∼1.6 g OVA protein),
e also simultaneously injected 50 g soluble OVA protein to the
ice to ensure that B cells and other APCs have equivalent access
o the antigen. Five days after the immunization, we observed sig-
iﬁcantly higher percentages of CXCR5+PD1+, CXCR5+Bcl6+ and
XCR5+IL-21+ Tfh cells both in the lymph nodes (Fig. 4A and B)
nd the spleen (Fig. 4C and D) from the CD8− DC targeted group
ompared with those from the CD8+ DC targeted group. In addi-
ion, the percentage of CD19+IgD−GL7+FAS+ GC B cells was  higher in
plenocytes from the CD8− DC targeted group (Fig. 4E and F). The
iters of OVA antigen speciﬁc IgM were observed to be comparable
etween CD8+ and CD8− DC targeted groups at day 3. At day 5,
VA antigen speciﬁc IgM or IgG titers were higher in the CD8− DC
argeted group compared with those in CD8+ DCs (Fig. 4G).
. Discussion
Modulating Tfh cell dependent humoral immune responses
s the key step to regulate defects in humoral immunity. How-
ver, the induction of Tfh cell differentiation by DCs has not been
learly understood. We  here investigated the undescribed intrin-
ic features of the two conventional DC subsets important for the
nitiation of Tfh cell differentiation.
It has been reported that the localization of DCIR2+CD4+ DCs
closely equivalent to DCIR2+CD8− DCs in this study) in the
Z bridging channel/inter-follicular region is mediated by the
hemotactic receptor EBI2 [19,20], having an important role in
nducing blood-borne particulate antigen speciﬁc CD4+ T cell and B
ell immune responses. Supported by these previous studies, we
uggest that the localization of DCIR2+CD8− DCs may  provide
dvantages in Tfh cell induction since we observed the recruit-
ent of antigen speciﬁc CD4+ T cells induced by CD8− DCs into MZ
ridging channels as early as 1 day after the stimulation. In addition,
hese CD4+ T cells localized in the MZ  bridging channels were pre-
umably mediated by the high level of CXCR5 and the low level of
CR7 expressions consistent with the previous studies [13,14]. The
D4+ T cells induced by CD8+ DCs expressed low level of CXCR5
nd high level of CCR7 which may  maintain their localization in
he T cell enriched region and result in the differentiation to IFN-
ecreting Th1 cells [10].
The fate of various CD4+ T cell subsets is often determined by the
ecretory cytokines [21], and IL-6 has been noted as a key cytokine
o induce Tfh cell differentiation [22]. Our previous study showed
hat the functional Tfh cells were well induced by CD8− DCs both
n the presence of poly (I:C) and LPS [10]. However, the two  DC sub-
ets displayed opposites in IL-6 secretion in the presence of poly
I:C) and LPS, suggesting the insigniﬁcance of DC-secreted IL-6 in
he induction of Tfh cells. Instead, the high levels of autocrine IL-
 (Fig. 3C) secreted from the antigen speciﬁcally activated CD4+tters 172 (2016) 21–28 27
T cells induced by CD8− DCs, independent of the adjuvant type,
seem to be critical for Tfh cell induction. The pro-inﬂammatory
cytokines such as IL-1 and TNF-, highly secreted from CD8+
DCs, may  have a role in inducing other CD4+ T cell subsets [21].
Previous studies reported the advantageous localization of
CD8− DCs in MZ  bridging channels to encounter antigen speciﬁc B
cells [18] as well as their slow rate of antigen internalization for pro-
longed antigen presentation [9], which may provide more chances
for B cells to uptake antigens, resulting in the highly activated
antigen speciﬁc B cells. However, we conﬁrmed the superiority of
CD8− DCs over other APCs in the initiation of functional Tfh cell
induction in the presence of excess OVA antigens. Nevertheless,
since the deﬁciency of functional B cells resulted in the decreased
number of Tfh cells [14,23], and since other DC subsets such as
late activator antigen-presenting cells [24], monocyte-derived DCs
[25], Langerhans cells [26] or CD103+dermal DCs [27] promote
functional Tfh cell differentiation upon different types of immune
responses, further researches are required to understand how APCs
interplay each other in the induction process of Tfh cells. In addi-
tion, given the previous reports demonstrating the involvement of
B cells and their products, the immunoglobulins in modulating DC
functions to induce distinct T cell subsets such as Treg or Th2 cells
[28,29], the role of B cells in CD8− DC induced Tfh cells needs to
be investigated.
Together with ICOSL and OX40L expressed on CD8− DCs in
inducing Tfh cells [10], supported by the previous studies demon-
strating the critical role of ICOSL and OX40L on dendritic cells or
APCs in inducing Tfh cells [30,31], the localization of CD8− DCs
in MZ  bridging channels may  provide synergic effects in the initia-
tion of Tfh cell differentiation. Other factors in DC subsets that may
need to be considered for Tfh cell differentiation are the difference
in antigen processing [9] and the duration of antigen presentation
[32,33].
In conclusion, we  show the previously undescribed intrinsic fea-
tures of CD8− DCs, suggesting its specialty in inducing functional
Tfh cells. Given the results we demonstrated so far, we provide
a rationale to ﬁnd the counterpart of CD8− DCs in humans to
develop efﬁcient DC-based vaccines for enhanced humoral immune
responses.
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